Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease

https://doi.org/10.1016/0090-6980(86)90225-XGet rights and content

Abstract

We studied the effect of prostacyclin /PGI2/ and its stable analog, iloprost, on blood fibrinolytic activity in 33 patients with peripheral arterial disease. Ten subjects /group A/ received three 5-hour infusions of iloprost on three consecutive days. The remaining 23 patients received three different 5-hour infusions /placebo, iloprost 2 ng/kg/min, PGI2 5 ng/kg/min/. Tissue plasminogen activator /t-PA/, total plasma fibrinolytic activity and euglobulin clot lysis time /ECLT/ were determined in patients before and after each infusion, both in freely flowing blood samples and following 10 min venous occlusion. In patients of group A, ECLT at rest was significantly shortened after all three iloprost infusions /on average by about 5–11%/. First and third infusions produced also shortening of ECLT after venostasis /by 21 and 32%/. Statistically significant rise in t-PA activity /by about 68% on average/ accompanied only the first infusion. In patients of the group B iloprost provoked significant fall in ECLT at rest /by about 19% on average/ only. PGI2 shortened ECLT both at rest and after venous occlusion /by about 17% and 20% on average, respectively/ and led to a rise in t-PA activity after venous occlusion by about 33% on average. Our results indicate that prostacyclin and its stable analog, iloprost, enhance fibrinolytic activity in man by releasing or facilitating the release of tissue plasminogen activator from the vessel wall.

References (30)

  • J.J.F. Belch et al.

    The effects of intravenous ZK 36–374, a stable prostacyclin analogue on normal volunteers

    Prostaglandins

    (1984)
  • D.R. Rosing et al.

    The fibrinolytic response of man to vasoactive drugs measured in arterial blood

    Thromb. Res.

    (1978)
  • Am. Dembińska-Kieć et al.

    Beta-pyridylcarbinol /Ronicol/ releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans

    Pharmacol. Res. Commun.

    (1983)
  • A. Szczeklik et al.

    Prostaglandins in therapy of cardiovascular disease

  • T. Utsunomiya et al.

    Treatment of pulmonary embolism with prostacyclin

    Surgery

    (1980)
  • Cited by (55)

    • Early Use of Iloprost in Nonfreezing Cold Injury

      2022, Wilderness and Environmental Medicine
      Citation Excerpt :

      Already a recognized treatment of acute frostbite, iloprost is a synthetic prostaglandin I2 analogue with vasodilatory properties.4 It has an inhibitory effect on platelet aggregation and also stimulates release of endogenous tissue plasminogen activator, resulting in a thrombolytic effect.5 The intravenous infusion is started at 0.5 mcg·kg·min-1, incrementally increased every 30 min by 0.5 mcg·kg·min-1, up to a maximum of 2 mcg·kg·min-1.

    • The role of fibrinogen and fibrinolysis in peripheral arterial disease

      2008, Thrombosis Research
      Citation Excerpt :

      Hematocrit, platelet count and fibrinogen levels were not modified during prostacyclin infusion [83]. Prostacyclin and its stable synthetic analog, iloprost, enhance fibrinolytic activity in PAD by releasing or facilitating the release of t-PA from the vessel wall [84]. Additionally, both short- and long-term treatment with iloprost significantly reduces PAI-1 Act, while long-term treatment significantly increases walking distance [85].

    • Intermittent pneumatic compression devises - Physiological mechanisms of action

      2001, European Journal of Vascular and Endovascular Surgery
    • Treatment of severe frostbite with Iloprost in Northern Canada

      2016, CMAJ
      Citation Excerpt :

      Alteplase is a recombinant tissue plasminogen activator. With its thrombolytic properties, it reverses the small-vessel thrombosis that occurs in frostbite and helps to restore perfusion to frostbitten digits.12 In the published studies,2–4 alteplase was associated with a decrease in the rate of amputation of severely frostbitten digits.

    View all citing articles on Scopus
    View full text